Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.21M Buy
74,658
+2,915
+4% +$208K ﹤0.01% 1436
2026
Q1
$2.93M Buy
71,743
+286
+0.4% +$15.2K ﹤0.01% 1845
2025
Q4
$4.25M Buy
71,457
+9,017
+14% +$508K ﹤0.01% 1544
2025
Q3
$3.4M Sell
62,440
-54,938
-47% -$2.38M ﹤0.01% 1545
2025
Q2
$3.97M Buy
117,378
+51,029
+77% +$1.5M ﹤0.01% 1817
2025
Q1
$1.65M Sell
66,349
-889
-1% -$27.9K ﹤0.01% 2081
2024
Q4
$2.87M Buy
67,238
+4,291
+7% +$121K ﹤0.01% 1878
2024
Q3
$1.16M Sell
62,947
-4,824
-7% -$79.2K ﹤0.01% 2328
2024
Q2
$783K Buy
67,771
+20,165
+42% +$317K ﹤0.01% 2485
2024
Q1
$804K Sell
47,606
-285
-0.6% -$7.73K ﹤0.01% 2113
2023
Q4
$1.72M Buy
47,891
+9,861
+26% +$211K ﹤0.01% 1764
2023
Q3
$646K Buy
+38,030
New +$720K ﹤0.01% 2179
2022
Q4
Sell
-4,800
Closed -$273K 2741
2022
Q3
$273K Buy
+4,800
New +$224K ﹤0.01% 2519
2021
Q3
Sell
-50,000
Closed -$4.37M 2780
2021
Q2
$4.37M Buy
+50,000
New +$4.37M ﹤0.01% 1434

Other funds holding XMTR

UBS AM's XMTR Position: Q2 2026 in Review

UBS AM increased its Xometry (XMTR) stake by 4.1% in Q2 2026, buying an estimated $208K and bringing the position to 74,658 shares worth $7.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

UBS AM first reported a position in XMTR in Q2 2021 and has held it in 14 quarters since. 293 funds tracked by Wall St. Rank hold XMTR as of Q2 2026.

  • UBS AM held 74,658 shares of Xometry worth $7.21M as of Q2 2026.
  • UBS AM bought 2,915 Xometry shares in Q2 2026, an estimated $208K.
  • Xometry made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1436 holding.
  • UBS AM first reported a position in Xometry in Q2 2021 and has held it in 14 quarters since.
  • 293 funds tracked by Wall St. Rank held Xometry as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.